{"id":111189,"date":"2021-08-05T09:14:47","date_gmt":"2021-08-05T01:14:47","guid":{"rendered":"https:\/\/www.chinamoneynetwork.com\/?p=125847"},"modified":"2021-08-05T09:14:47","modified_gmt":"2021-08-05T01:14:47","slug":"china-tech-digest-sensetime-launches-ai-drug-development-byd-starts-data-cooperation-with-vastbase-2","status":"publish","type":"post","link":"https:\/\/www.chinalegalblog.com\/en\/2021\/08\/05\/china-tech-digest-sensetime-launches-ai-drug-development-byd-starts-data-cooperation-with-vastbase-2\/","title":{"rendered":"China Tech Digest: SenseTime Launches AI Drug Development; BYD Starts Data Cooperation With Vastbase"},"content":{"rendered":"<img width=\"696\" height=\"429\" src=\"https:\/\/assets.chinamoneynetwork.com\/wp-content\/uploads\/20191225112429\/AInnovation.jpg\" class=\"webfeedsFeaturedVisual wp-post-image\" alt=\"\" loading=\"lazy\" style=\"display: block; margin: auto; margin-bottom: 5px;max-width: 100%;\" link_thumbnail=\"\" srcset=\"https:\/\/assets.chinamoneynetwork.com\/wp-content\/uploads\/20191225112429\/AInnovation.jpg 800w, https:\/\/assets.chinamoneynetwork.com\/wp-content\/uploads\/20191225112429\/AInnovation-300x185.jpg 300w, https:\/\/assets.chinamoneynetwork.com\/wp-content\/uploads\/20191225112429\/AInnovation-768x473.jpg 768w, https:\/\/assets.chinamoneynetwork.com\/wp-content\/uploads\/20191225112429\/AInnovation-356x220.jpg 356w, https:\/\/assets.chinamoneynetwork.com\/wp-content\/uploads\/20191225112429\/AInnovation-712x440.jpg 712w, https:\/\/assets.chinamoneynetwork.com\/wp-content\/uploads\/20191225112429\/AInnovation-696x429.jpg 696w, https:\/\/assets.chinamoneynetwork.com\/wp-content\/uploads\/20191225112429\/AInnovation-600x370.jpg 600w\" sizes=\"(max-width: 696px) 100vw, 696px\" \/><p>SenseTime launches AI drug development SenseTime published a number of latest research results, covering drug discovery, preclinical research, clinical trials, post-marketing of new drugs and other drug development links, aiming to accelerate new drug research and marketing process through AI technology, shorten the new drug R&#038;D cycle, and reduce drugs R&#038;D costs and increase the [&#8230;]<\/p>\n<p><a rel=\"nofollow\" href=\"https:\/\/www.chinamoneynetwork.com\/2021\/08\/05\/china-tech-digest-sensetime-launches-ai-drug-development-byd-starts-data-cooperation-with-vastbase\">China Tech Digest: SenseTime Launches AI Drug Development; BYD Starts Data Cooperation With Vastbase<\/a> comes from <a rel=\"nofollow\" href=\"https:\/\/www.chinamoneynetwork.com\/\">China Money Network<\/a>: Primary Data for China's Primary Markets! All Rights Reserved.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>SenseTime launches AI drug development SenseTime published a number of latest research results, covering drug discovery, preclinical research, clinical trials, post-marketing of new drugs and other drug development links, aiming to accelerate new drug &#8230;<\/p>\n","protected":false},"author":251,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[414,705,194,484],"tags":[4617,8977,8950],"class_list":["post-111189","post","type-post","status-publish","format-standard","hentry","category-baidu","category-fujian","category-news-chinese-law","category-united-states","tag-qiming-venture-partners","tag-sensetime","tag-tech"],"_links":{"self":[{"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/posts\/111189","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/users\/251"}],"replies":[{"embeddable":true,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/comments?post=111189"}],"version-history":[{"count":1,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/posts\/111189\/revisions"}],"predecessor-version":[{"id":111190,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/posts\/111189\/revisions\/111190"}],"wp:attachment":[{"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/media?parent=111189"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/categories?post=111189"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/tags?post=111189"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}